ELOX

Conviction 74Scan · Mon, Aug 10, 2026

ELOX$17.66+0.51%

ResistanceSupportVol 14

Vol MA14 79.75K

Jun 9Jun 22Jul 6Jul 16Jul 29Aug 10

Eloxx Pharmaceuticals, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.eloxxpharma.com ↗

Price17.66

Change+0.51%

Gap+1.94%

Rel volume1.74×

Avg volume68K

Avg $ vol939.74K

SMA 2014.18

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 11.62

RSI (14)69

MACD hist0.48

MACD cross—

Stoch %K / %D80 / 80

ADX (14)45

+DI / −DI26 / 8

RSI divergence—

MACD divergence—

ATR %+11.93%

ADR %13.35%

52w high18.45

52w low10.95

From 52w high-4.28%

Above 52w low+61.28%

New 52w highNo

SqueezeOff

Bollinger width77.69%

%B0.82

Donchian pos79.74%

Donchian high19.36

Donchian low10.98

AVWAP (52w high)17.84

vs AVWAP high-1.03%

AVWAP (52w low)13.06

vs AVWAP low+35.20%

OBV trendUp

Chaikin MF (20)0.26

Today vs 20d1.74×

Avg vol (14d)79.75K

Avg vol (20d)68K

Avg $ vol (20d)939.74K

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank82.7

1 week-4.28%

1 month+49.53%

3 months—

6 months—

1 year—

YTD+60.40%

P/E-22.79

P/B-18.01

P/S—

P/FCF-21.37

EPS-0.4900

Div yield—

ROE79.05%

ROA-70.50%

Debt/Eq0.00

Current0.53

EV/EBITDA-20.37

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-90.74%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value130.23M

Revenue0

Net income-3.75M

Gross profit—

Free cash flow-6.39M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out3.92M

Employees7

ListedFri, Dec 11, 1998

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction74 / 100

Pattern quality—

Tech rank82.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance17.65

Support10.00

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ELOX

All disclosures →

No recent disclosed trades by Congress in ELOX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ELOX · 6 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Aggarwal Sumit President and CEO · Stock Option (Right to Buy) · 2026-06-10	Grant	328.83K	$0	2026-06-10	2026-06-10
Kjellson Nina S Director · Stock Option (Right to Buy) · 2026-06-08	Grant	13.59K	$0	2026-06-08	2026-06-10
Rubin Steven D Director · Stock Option (Right to Buy) · 2026-06-08	Grant	4.02K	$0	2026-06-08	2026-06-10
Walts Alan Edmund Director · Stock Option (Right to Buy) · 2026-06-08	Grant	8.59K	$0	2026-06-08	2026-06-10
Webster Stephen W Director · Stock Option (Right to Buy) · 2026-06-08	Grant	13.59K	$0	2026-06-08	2026-06-10
Domicilium Real Estate Fund III LP 10% owner · Pre-funded Warrant · 2026-05-27	Acquire	113.64K	—	2026-05-27	2026-06-05
Domicilium Real Estate Fund III LP 10% owner · Pre-funded Warrant · 2026-05-27	Other	—	—	2026-05-27	2026-06-05
Domicilium Real Estate Fund III LP 10% owner · Common Stock, $0.01 par value per share · 2026-05-27	Dispose	113.64K	$0	2026-05-27	2026-06-05
Domicilium Real Estate Fund III LP 10% owner · Common Stock, $0.01 par value per share · 2026-05-27	Other	—	—	2026-05-27	2026-06-05
Coastlands Capital LP 10% owner · Common Stock · 2026-05-27	Dispose	1.25M	$0	2026-05-27	2026-05-29

SEC filings

EDGAR filings in ELOX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.